Jaguar Health, Inc.
JAGX
$1.89
-$0.10-5.03%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -40.65M | -39.73M | -38.49M | -37.74M | -35.67M |
| Total Depreciation and Amortization | 2.29M | 2.29M | 2.36M | 2.36M | 2.39M |
| Total Amortization of Deferred Charges | 0.00 | 0.00 | 274.00K | 1.98M | 9.07M |
| Total Other Non-Cash Items | 10.35M | 9.32M | 9.49M | 9.29M | 5.07M |
| Change in Net Operating Assets | 325.00K | -1.54M | -3.01M | -4.90M | -10.32M |
| Cash from Operations | -27.68M | -29.65M | -29.38M | -29.01M | -29.46M |
| Capital Expenditure | 0.00 | -16.00K | -16.00K | -16.00K | -16.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -215.00K | -215.00K | -215.00K | -- | -- |
| Cash from Investing | -215.00K | -231.00K | -231.00K | -16.00K | -16.00K |
| Total Debt Issued | 3.45M | 3.45M | -- | -- | -- |
| Total Debt Repaid | -775.00K | -724.00K | -708.00K | -1.15M | -926.00K |
| Issuance of Common Stock | 11.41M | 21.31M | 32.07M | 39.12M | 36.78M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | 0.00 | 0.00 |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -95.00K | -132.00K | -157.00K | 1.05M | 1.05M |
| Cash from Financing | 13.98M | 23.90M | 31.20M | 39.02M | 36.90M |
| Foreign Exchange rate Adjustments | 68.00K | 1.00K | -54.00K | 46.00K | -5.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -13.84M | -5.98M | 1.53M | 10.04M | 7.42M |